GC Genome Corporation

340450KOSDAQOther scientific and technical services

GC Genome Corporation (340450, KOSDAQ) reported KRW 32bn revenue in 2025.

Reported financials

Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.

YearRevenueOperating profitNet profitAssetsEquityBasis
2023
2024
202532148578Separate

Ratios, year by year

Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.

YearOperating marginNet marginEquity / assetsReturn on equity
2023
2024
20253.9%12.8%92.5%5.2%

These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.

Market size

Market capitalisationKRW 142bn
Close priceKRW 6,020
Listed shares23,650,793
Price as of20260909

Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.

Workforce — a side measure, not the main one

Employees (2025)131
Women83 (63.4%)
Average tenure3.8 years
Annual pay, menKRW 64,000,000
Annual pay, womenKRW 47,000,000
Pay ratio, women to men73.4%

Other companies in Other scientific and technical services

18 listed companies file under this classification. Showing 12.

See the whole Other scientific and technical services list →